Skip to main content
辰光医疗 logo

辰光医疗 — Investor Relations & Filings

Ticker · 920300 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2024-04-22 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920300

About 辰光医疗

http://www.shanghaicg.net/

Shanghai Chenguang Medical Technologies Co., Ltd. specializes in the research, development, and manufacturing of core components for Magnetic Resonance Imaging (MRI) systems. The product portfolio includes high-performance radiofrequency (RF) coils, superconducting magnets, and gradient coils designed for clinical, preclinical, and veterinary applications. The company focuses on high-field and ultra-high-field MRI technology, providing customized hardware solutions and integrated components to global imaging equipment manufacturers. Its technical capabilities encompass electromagnetic simulation, structural design, and precision manufacturing of specialized imaging hardware.

Recent filings

Filing Released Lang Actions
董事会关于独立董事独立性情况的专项意见
Board/Management Information Classification · 95% confidence The document is a formal announcement from the board of directors regarding the independence of the company's independent directors. It references regulatory requirements from the China Securities Regulatory Commission and provides a detailed assessment of the independence criteria for the directors. The content is focused on governance and compliance with independence standards rather than financial results, management changes, or shareholder votes. It is not a full report but a specific board/management information disclosure about director independence. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length and content do not suggest it is an AGM presentation, voting results, or regulatory filing fallback.
2024-04-22 Chinese
独立董事2023年度述职报告（郭宁）
Board/Management Information Classification · 95% confidence The document is titled as an independent director's annual duty report for the year 2023 from Shanghai Chunguang Medical Technology Co., Ltd. It details the attendance and participation of the independent director in board meetings, committees, and opinions expressed on various company matters during the year. The content focuses on the director's activities, responsibilities, and compliance with relevant laws and regulations. It is not a financial report, audit report, or earnings release, nor is it an announcement of voting results or capital changes. It is a management-related report specifically about board/management information concerning the independent director's role and activities. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is under 5,000 characters and contains substantive content about management activities, not just an announcement or certification, so it is not RPA or RNS.
2024-04-22 Chinese
提供担保暨关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a guarantee provided by Shanghai Chenguang Medical Technology Co., Ltd. for its wholly-owned subsidiary, including details about the guarantee, related party transactions, board approvals, and opinions from the sponsor institution. It includes no financial statements or comprehensive financial data but focuses on the guarantee and related transaction disclosures. The document length is 2255 characters, which is relatively short and primarily serves as a formal announcement of a corporate action rather than a full financial report or audit. This fits the profile of a Regulatory Filing (RNS) as it is a general regulatory announcement about a guarantee and related party transaction, not an annual report, audit report, or other specific financial filing.
2024-04-22 Chinese
关于拟变更公司经营范围并修订《公司章程》的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shanghai Chenguang Medical Technology Co., Ltd. regarding proposed amendments to the company's business scope and revisions to the Articles of Association. It includes detailed changes to the company's registered business activities and governance provisions. The document is a formal announcement of these proposed changes and states that the amendments will be submitted to the shareholders' meeting for approval. There is no financial data, audit information, or report attached. The document is not a full report but an official announcement of corporate governance and operational scope changes. This fits best under the category of Regulatory Filings (RNS), as it is a general regulatory announcement about company governance and business scope changes that does not fit other more specific categories.
2024-04-22 Chinese
关于公司及子公司取得《辐射安全许可证》的公告
Regulatory Filings Classification · 100% confidence The document is an official announcement from Shanghai Chenguang Medical Technology Co., Ltd. regarding the company and its subsidiary obtaining Radiation Safety Permits issued by the Shanghai Municipal Ecology and Environment Bureau. It details the permit numbers, validity periods, and the legal basis for the permits. There is no financial data, no mention of financial results, no discussion of management changes, no voting results, no legal proceedings, no capital changes, and no reference to any report publication. The document is a regulatory announcement about compliance and licensing. It fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2024-04-22 Chinese
关于取得中标通知书的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shanghai Chenguang Medical Technology Co., Ltd. about receiving a bid-winning notification for a medical equipment procurement project. It details the project, the impact on the company, and risk warnings. There is no financial data, no mention of a report being attached or published, and no indication of a regulatory filing or certification. The content is about a contract award and its business impact, which fits best under a general regulatory announcement category rather than a financial report or management change. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2024-04-16 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.